Incube Labs
Multi-disciplinary life-sciences research and incubator organization focused on developing and commercializing medical innovations across devices, drug-device combinations, biologics delivery and biomaterials. Offers end-to-end capabilities from early-stage discovery and prototyping through manufacturing scale-up, regulatory strategy and clinical translation to create new therapeutic approaches.
Industries
Nr. of Employees
medium (51-250)
Incube Labs
Products
Oral biologics delivery platform (preclinical / translational)
Technology platform developed to enable oral administration of biologic therapeutics with demonstrated preclinical bioavailability.
Implantable localized drug-delivery device (preclinical)
Implantable device designed to bypass the blood-brain barrier and provide localized drug delivery to tumor sites for gliomas.
Neuromodulation therapy platforms
Implantable neuromodulation systems under development for indications such as overactive bladder and epilepsy.
Remote patient monitoring platform for implanted devices
Wireless remote-management platform intended to monitor and manage patients with active implanted medical devices.
Oral biologics delivery platform (preclinical / translational)
Technology platform developed to enable oral administration of biologic therapeutics with demonstrated preclinical bioavailability.
Implantable localized drug-delivery device (preclinical)
Implantable device designed to bypass the blood-brain barrier and provide localized drug delivery to tumor sites for gliomas.
Neuromodulation therapy platforms
Implantable neuromodulation systems under development for indications such as overactive bladder and epilepsy.
Remote patient monitoring platform for implanted devices
Wireless remote-management platform intended to monitor and manage patients with active implanted medical devices.
Services
Discovery-stage research, pharmacology studies, bioanalytical assay development and preclinical model evaluation to support therapeutic and device programs.
Rapid prototyping, design-for-manufacture, process optimization and support for scale-up to production for Class II/III medical devices and implantable components.
Regulatory planning, quality management system implementation, risk management, and preparation for regulatory submissions for devices, drugs and combination products.
Development of ATE systems and test procedures, test software, and verification/validation support for manufacturing lines.
Discovery-stage research, pharmacology studies, bioanalytical assay development and preclinical model evaluation to support therapeutic and device programs.
Rapid prototyping, design-for-manufacture, process optimization and support for scale-up to production for Class II/III medical devices and implantable components.
Regulatory planning, quality management system implementation, risk management, and preparation for regulatory submissions for devices, drugs and combination products.
Development of ATE systems and test procedures, test software, and verification/validation support for manufacturing lines.
Expertise Areas
- Implantable medical devices
- Drug-device combination development
- Biologics formulation and delivery
- Biomaterials and polymer chemistry
Key Technologies
- Implantable stimulators and leads
- Neuromodulation
- Oral biologics delivery platforms
- Transdermal delivery systems
News & Updates
Media coverage referencing proof-of-concept human or preclinical testing of an oral delivery approach for injectable drugs.
Press coverage describing a pill-based device designed to deliver medications via a microneedle for painless injections.
Reported metrics: number of companies founded, number of exits, and patent applications filed (as listed on site).
Founding of the research organization in 1995 and multiple subsequent company formations and acquisitions documented in the public timeline.
Media coverage referencing proof-of-concept human or preclinical testing of an oral delivery approach for injectable drugs.
Press coverage describing a pill-based device designed to deliver medications via a microneedle for painless injections.
Reported metrics: number of companies founded, number of exits, and patent applications filed (as listed on site).
Founding of the research organization in 1995 and multiple subsequent company formations and acquisitions documented in the public timeline.